License to FRoperate

Strange Tony,

Gentiva's press release on its closing the buyout of Promedica's hospice and home health operations had a strange name at the bottom.  Contact information was not for a Gentiva PR person but H/Advisors Abernathy.

At first I thought it might be another affiliate of Clayton, Dubilier and Rice given financial rapscallion's propensity to cross sell across their corporate holdings.  Then I found H/Advisors Abernathy had been helping private equity for 40 years.  No financial rapscallion holds onto an asset that long.

H/Advisors Abernathy "thinks like private equity", helps with add-on acquisitions can reach stakeholders who can impact private equity firms' license to operate, i.e. throw off huge amounts of cash to sponsors while shafting employees.

H/Advisors announced a new healthcare public policy influence effort (lobbying), bought Tinkle in Spain (our hospice physicians make us say urinate), and opened their first office in the Middle East (Dubai).  

Oddly the press release on the Gentiva Promedica purchase made no mention of CDR or the $500 million in added debt that will increase interest expense.  My bowels can feel more cost reduction efforts on the way.

H/Advisors knows financial rapscallions like to stay hidden from public view and they clearly did their job.  The CDR team appreciates it.

Anonymous